UPDATE Automox MCP Server 2.2 Brings Visual Review, Agentic Patch by Severity Policy Creation, and Live Capability Discovery to Endpoint Operations
Anaphora Events Now Available on SAP Store, Bringing On-Brand Event Execution into SAP CX Workflows
Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib
SIMCo Expands Infrastructure Debt Franchise through Strategic Partnerships with PIMCO and Investec
Eromnet Obtains Singapore MPI License, Expanding Global Fintech Business
Tecentriq significantly improved overall survival in people with high PD-L1 expression, compared with chemotherapy in…
Strong cash and cash equivalents position at March 31, 2021 of CHF25.2M ($26.7M) Completed $11.5M…
Saint-Herblain (France), May 5, 2021 – Valneva SE (the “Company”), a specialty vaccine company focused…
ROCKVILLE, Md., May 04, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
On track to refile Libervant™ (diazepam) Buccal Film New Drug Application (NDA) by end of…
BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a…
First-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progress PRINCETON, N.J.,…
Vertically-integrated cannabis leader finishes quarter with multiple post-merger successes and strong position for future expansion…
OXFORD, United Kingdom, May 04, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage…
Transformative, leading allogeneic NKT cell platform technology expands Athenex’s cell therapy development capability Platform has…
New Drug Application (NDA) submission for topical roflumilast cream as a potential treatment for plaque…
SAN CARLOS, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Multiple pre-clinical studies indicate that Lixte’s lead clinical drug candidate LB-100 enhances the effectiveness of…
ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021 Conference…
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life…
COPENHAGEN, Denmark, May 04, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Novel candidate in development aims to be first approved non-vaccine therapeutic for Lyme disease prevention…
DEER PARK, Ill., May 04, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
Prescription Growth Reflects Increasing Demand for Twirla Base of Prescribers Continues to Grow in First…